Bioventix PLC
LSE:BVXP

Watchlist Manager
Bioventix PLC Logo
Bioventix PLC
LSE:BVXP
Watchlist
Price: 3 750 GBX 1.08% Market Closed
Market Cap: 195.7m GBX
Have any thoughts about
Bioventix PLC?
Write Note

Intrinsic Value

The intrinsic value of one BVXP stock under the Base Case scenario is 3 076.09 GBX. Compared to the current market price of 3 750 GBX, Bioventix PLC is Overvalued by 18%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BVXP Intrinsic Value
3 076.09 GBX
Overvaluation 18%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Bioventix PLC

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for BVXP cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about BVXP?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Bioventix PLC

Provide an overview of the primary business activities
of Bioventix PLC.

What unique competitive advantages
does Bioventix PLC hold over its rivals?

What risks and challenges
does Bioventix PLC face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Bioventix PLC.

Provide P/S
for Bioventix PLC.

Provide P/E
for Bioventix PLC.

Provide P/OCF
for Bioventix PLC.

Provide P/FCFE
for Bioventix PLC.

Provide P/B
for Bioventix PLC.

Provide EV/S
for Bioventix PLC.

Provide EV/GP
for Bioventix PLC.

Provide EV/EBITDA
for Bioventix PLC.

Provide EV/EBIT
for Bioventix PLC.

Provide EV/OCF
for Bioventix PLC.

Provide EV/FCFF
for Bioventix PLC.

Provide EV/IC
for Bioventix PLC.

Show me price targets
for Bioventix PLC made by professional analysts.

What are the Revenue projections
for Bioventix PLC?

How accurate were the past Revenue estimates
for Bioventix PLC?

What are the Net Income projections
for Bioventix PLC?

How accurate were the past Net Income estimates
for Bioventix PLC?

What are the EPS projections
for Bioventix PLC?

How accurate were the past EPS estimates
for Bioventix PLC?

What are the EBIT projections
for Bioventix PLC?

How accurate were the past EBIT estimates
for Bioventix PLC?

Compare the revenue forecasts
for Bioventix PLC with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Bioventix PLC and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Bioventix PLC against its competitors.

Analyze the profit margins
(gross, operating, and net) of Bioventix PLC compared to its peers.

Compare the P/E ratios
of Bioventix PLC against its peers.

Discuss the investment returns and shareholder value creation
comparing Bioventix PLC with its peers.

Analyze the financial leverage
of Bioventix PLC compared to its main competitors.

Show all profitability ratios
for Bioventix PLC.

Provide ROE
for Bioventix PLC.

Provide ROA
for Bioventix PLC.

Provide ROIC
for Bioventix PLC.

Provide ROCE
for Bioventix PLC.

Provide Gross Margin
for Bioventix PLC.

Provide Operating Margin
for Bioventix PLC.

Provide Net Margin
for Bioventix PLC.

Provide FCF Margin
for Bioventix PLC.

Show all solvency ratios
for Bioventix PLC.

Provide D/E Ratio
for Bioventix PLC.

Provide D/A Ratio
for Bioventix PLC.

Provide Interest Coverage Ratio
for Bioventix PLC.

Provide Altman Z-Score Ratio
for Bioventix PLC.

Provide Quick Ratio
for Bioventix PLC.

Provide Current Ratio
for Bioventix PLC.

Provide Cash Ratio
for Bioventix PLC.

What is the historical Revenue growth
over the last 5 years for Bioventix PLC?

What is the historical Net Income growth
over the last 5 years for Bioventix PLC?

What is the current Free Cash Flow
of Bioventix PLC?

Discuss the annual earnings per share (EPS)
trend over the past five years for Bioventix PLC.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Bioventix PLC

Current Assets 12m
Cash & Short-Term Investments 5.5m
Receivables 5.9m
Other Current Assets 585.7k
Non-Current Assets 1.1m
Long-Term Investments 610k
PP&E 522.7k
Current Liabilities 1.7m
Accounts Payable 1.7m
Non-Current Liabilities 6.7k
Other Non-Current Liabilities 6.7k
Efficiency

Earnings Waterfall
Bioventix PLC

Revenue
13.6m GBP
Cost of Revenue
-850.5k GBP
Gross Profit
12.7m GBP
Operating Expenses
-2m GBP
Operating Income
10.8m GBP
Other Expenses
-2.1m GBP
Net Income
8.7m GBP

Free Cash Flow Analysis
Bioventix PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

BVXP Profitability Score
Profitability Due Diligence

Bioventix PLC's profitability score is 89/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional 3-Year Average ROIC
Positive Free Cash Flow
Positive Gross Profit
89/100
Profitability
Score

Bioventix PLC's profitability score is 89/100. The higher the profitability score, the more profitable the company is.

BVXP Solvency Score
Solvency Due Diligence

Bioventix PLC's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Bioventix PLC's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BVXP Price Targets Summary
Bioventix PLC

Wall Street analysts forecast BVXP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BVXP is 5 202 GBX with a low forecast of 5 151 GBX and a high forecast of 5 355 GBX.

Lowest
Price Target
5 151 GBX
37% Upside
Average
Price Target
5 202 GBX
39% Upside
Highest
Price Target
5 355 GBX
43% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for BVXP?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for BVXP is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Bioventix PLC Logo
Bioventix PLC

Country

United Kingdom

Industry

Biotechnology

Market Cap

195.7m GBP

Dividend Yield

4.13%

Description

Bioventix Plc engages in the development and supply of antibodies. The company is headquartered in Farnham, Surrey and currently employs 17 full-time employees. The company went IPO on 2014-04-29. The principal activity of the Company is the development and supply of antibodies. The firm specializes in the development of sheep monoclonal antibodies (SMAs) for use in immunodiagnostics focusing on the areas of clinical diagnostics, such as in automated immunoassays used in blood testing. The firm offers a portfolio of antibodies to customers for both commercial use and research and development (R&D) purposes, for the diagnosis or monitoring of a range of conditions, including heart disease, cancer, fertility, thyroid function and drug abuse. The firm also supplies antibody products and services to multinational clinical diagnostics companies. The firm sells its products through direct sales and through distributors.

Contact

SURREY
Farnham
7 Romans Business Park, East Street
+441252728001.0
www.bioventix.com

IPO

2014-04-29

Employees

17

Officers

CEO & Director
Mr. Peter John Harrison MA
CFO & Director
Mr. Bruce Edward Heath Hiscock

See Also

Discover More
What is the Intrinsic Value of one BVXP stock?

The intrinsic value of one BVXP stock under the Base Case scenario is 3 076.09 GBX.

Is BVXP stock undervalued or overvalued?

Compared to the current market price of 3 750 GBX, Bioventix PLC is Overvalued by 18%.

Back to Top